Bausch Health
BHC
#3923
Rank
S$4.21 B
Marketcap
S$11.25
Share price
3.07%
Change (1 day)
39.94%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): S-$2.92

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is S-$2.93. In 2025 the company made an earnings per share (EPS) of S$0.54 an increase over its 2024 EPS that were of S-$0.15.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$2.92-638.7%
2025S$0.54-450%
2024S-$0.15-92.59%
2023S-$2.09160.89%
2022S-$0.80-76.64%
2021S-$3.4368.45%
2020S-$2.03-68.91%
2019S-$6.54-57.11%
2018S-$15.25-272.22%
2017S$8.86-199.29%
2016S-$8.92798.7%
2015S-$0.99-128.31%
2014S$3.51-204.62%
2013S-$3.35602.7%
2012S-$0.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.24-91.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.22-58.15%๐Ÿ‡บ๐Ÿ‡ธ USA